Clinical Trial Update: Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial assessed dose-related effects of Vitamin D3 on immune responses in patients with Clinically Isolated Syndrome and Multiple Sclerosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University College Dublin | Conditions: Clinically Isolated Syndrome, Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED